Search


 
Results 51 - 60 of about 77 for "FDA update".

January 8, 2016 | ACP Diabetes Monthly

... 30 kg/m 2 or greater. FDA update. Rosiglitazone REMS ends, new insulin approved. The FDA has determined that the Risk ...

August 8, 2014 | ACP Diabetes Monthly

... meta-analysis found. FDA update. Empagliflozin approved to treat type 2 diabetes. Empagliflozin (Jardiance), a sodium ...

September 11, 2015 | ACP Diabetes Monthly

... myocardial infarction, or stroke). FDA update. Warning on DPP-4 inhibitors and insulin recall. Dipeptidyl peptidase-4 (DPP ...

October 10, 2014 | ACP Diabetes Monthly

... a draft recommendation released this week. FDA update. New GLP-1 agonist approved. A new glucagon-like peptide-1 ...

September 14, 2012 | ACP Diabetes Monthly

... be for individual appointments. FDA update. New weight loss drug approved. Lorcaserin hydrochloride (Belviq) was recently ...

May 9, 2014 | ACP Diabetes Monthly

... in the April ACP Hospitalist. FDA update. New GLP-1 receptor agonist approved. Albiglutide (Tanzeum), a glucagon-like ...

April 10, 2015 | ACP Diabetes Monthly

... study notes. FDA update. Aflibercept approved for diabetic retinopathy in diabetic macular edema. Aflibercept (Eylea) has ...

June 14, 2013 | ACP Diabetes Monthly

... results, consider several possibilities. FDA update. First drug in new class approved. The FDA recently approved canaglifozin ...

February 14, 2014 | ACP Diabetes Monthly

... rate of cardiovascular events. FDA update. Saxagliptin under analysis for heart failure risk. The FDA has requested clinical ...

Insulin needles failing to deploy | ACP Diabetes Monthly

Several lots of the OmniPod Insulin Management System were affected by a recent field safety notification about needle mechanisms failing to deploy ...

Result Page: < Previous  1 2 3 4 5 6 7 8  Next >